Merck Provides Update on Phase 3 KEYNOTE-062 Trial Evaluating KEYTRUDA
Merck finds Keytruda no better than chemo as a first-line treatment for gastric cancer, according to a Phase 3 study. Results of... Read More
How inflammation causes gastric cancer
In a study, scientists blocked a protein pathway that causes the proliferation of gastric epithelial cells from H. Pylori infection and prevented... Read More
Intestinal and diffuse gastric cancer: a retrospective study comparing primary sites
A retrospective study compares the significant difference in the spread patterns of intestinal gastric cancer to that of diffuse subtype and finds... Read More
Safety and efficacy of nivolumab in combination with S-1/capecitabine plus oxaliplatin in patients with previously untreated, unresectable, advanced, or recurrent gastric/gastroesophageal junction cancer: interim results of a randomized, phase II trial
In the randomized, phase II (part 1) ATTRACTION-4 trial, nivolumab combined with chemotherapy [S-1 plus oxaliplatin (SOX) or capecitabine plus oxaliplatin (CapeOX)]... Read More
Comparison of Four Front-Line Doublets in Asian Patients With Metastatic Gastric Cancer
In a Phase II trial, four front-line chemotherapy doublets were compared for treatment of patients with metastatic gastric cancer. While one group... Read More
Second primary cancers and survival in patients with gastric cancer: association with prediagnosis lifestyles
Heavy alcohol consumption and an unhealthy diet prior to a diagnosis of gastric cancer can affect treatment outcomes, a new study shows.
Addition of docetaxel to oral fluoropyrimidine improves efficacy in patients with stage III gastric cancer
A new study suggests that adding docetaxel to fluoropyrimidine post surgery is effective in stage 3 gastric cancer.
Nutrition for Patients With Mucositis
Dr. Jann Arends discusses the importance of considering nutritional treatment for #cancer patients with mucositis, painful inflammation and ulceration of the mucous... Read More
Perioperative Fluorouracil + Leucovorin, Oxaliplatin, and Docetaxel vs Fluorouracil or Capecitabine + Cisplatin and Epirubicin for Locally Advanced, Resectable Gastric or GE Junction Adenocarcinoma
A phase II/III trial investigated a chemotherapy triplet, FLOT (docetaxel, oxaliplatin, 5-FU/LV), as perioperative therapy in resectable gastroesophageal cancers compared with ECF/ECX,... Read More
Effect of Vitamin D Supplementation on Relapse-Free Survival Among Patients With Digestive Tract Cancers
A large randomized trial concluded that Vitamin D supplementation does not improve relapse-free survival in patients with cancers of the digestive tract.
